FIELD: pharmacology.
SUBSTANCE: means with antiarrhythmic action is a substance isolated from plants of the Aconitum genus of the Ranunculaceae (buttercup) family containing lappaconitine, N-acetylsepaconitine alkaloids. 1-desmethyl-l-paconitine, ranaconitine, N-desacetyl-l-paconitine, isolappaconitine, 9-deoxylpaconitine or pharmaceutically acceptable salts thereof. A pharmaceutical composition for oral administration with an antiarrhythmic effect. The above described agent is an effective and safe antiarrhythmic drug, reduces the risk of sudden cardiac death, can be used in the treatment of arrhythmia in patients with chronic obstructive pulmonary disease (COPD) and epilepsy, and has high antiarrhythmic activity in various forms of arrhythmia.
EFFECT: broncholytic, antiepileptic, anti-inflammatory and local anesthetic properties.
9 cl, 19 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROCESS FOR MANUFACTURING ANTIARRYTHMIC COMPOSITION | 1992 |
|
RU2039568C1 |
| ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
| AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
| DRUG PREPARATION FOR TREATING CARDIAC ARRHYTHMIA | 2013 |
|
RU2513580C1 |
| METHOD FOR OBTAINING MEANS WITH ANTI-ARITHMAL ACTION | 2016 |
|
RU2624240C1 |
| ANTIARRHYTHMIC AGENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION BASED ON ANTIARRHYTHMIC AGENT | 2022 |
|
RU2825632C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
| N-(BETA-HYDROXYETHYL)-CYTISINE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228179C2 |
| ORGANIC SALTS N1-(2,3,4-TRIMETHOXYBENZYL)-N2-{2-[(2,3,4-TRIMETHOXYBENZYL)AMINO]ETHYL}-1,2-ETHANE-DIAMINE | 2022 |
|
RU2813347C2 |
| 5'-BROMOLAPPACONITINE HYDROBROMIDE POSSESSING ANTI-ARRHYTHMIC ACTIVITY | 2005 |
|
RU2295524C1 |
